Medical term:

RID

Abbreviation for radial immunodiffusion.

Farlex Partner Medical Dictionary © Farlex 2012

RID

Abbreviation for:
radial immunodiffusion
radioimmunodetection
Regional Implementation Directors, see there
Registry of Interpreters for the Deaf
remission-inducing drug
restless, irritable and discontented
ruptured intervertebral disc

RID

Radial immunodiffusion, see there.

donor

(do'nor) [Fr. doneur fr L. donator, giver, donor]

1. A person or animal that furnishes blood, tissue, or an organ to be used in another person.

2. In chemistry, a compound that frees part of itself to unite with another compound called an acceptor.

artificial insemination donor

Abbreviation: AID

A male who provides sperm to be used to fertilize a woman seeking to become pregnant.

blood donor

One who gives blood (or its components) to be used for transfusion.

cadaveric donor

One who donates an organ or tissue after his or her death.

directed donor

A family member, friend, or significant other who gives blood, an organ, or tissue to another person to support a vital function or prevent death.

HLA-mismatched related donor

Mismatched related donor.

human leukocyte antigen matched unrelated donor

Matched unrelated donor.

hydrogen donor

In oxidation-reduction reactions, a substance that gives up hydrogen atoms to another substance, the acceptor.

See: hydrogen acceptor

living donor

One who donates an organ or tissue while he or she is still living. Living donors must be healthy and antigenically matched to the recipient.

matched unrelated donor

Abbreviation: MUD

One who donates an organ or tissue (such as bone marrow stem cells) to another person with human leukocyte antigens identical to those of the organ recipient.

Synonym: human leukocyte antigen matched unrelated donor

mismatched related donor

Abbreviation: MMRD

An organ or tissue donor who is a family member of the organ recipient but whose human leukocyte antigens are not identical to those of the recipient. In general in organ transplantation, organ and recipient survival are highest when the donor and the recipient share the same HLA antigens.

Synonym: HLA-mismatched related donor

nondirected donor

A person who donates blood, an organ, or tissue to the community at large and is unknown to the recipient.

related HLA-identical donor

Related identical donor.

related identical donor

Abbreviation: RID

A family member who donates an organ or tissue (such as a kidney or bone marrow stem cells) to another family member who shares perfectly matched human leukocyte antigens. Organ transplantations from RIDs have higher success rates than transplants obtained from mismatched related donors (MMRDs) or from matched unrelated donors (MUDs).

Synonym: related HLA-identical donor

universal donor

A person who has group O red blood cells. In a life-threatening emergency this person's cells can be transfused into any patient in need of red blood cells.

related identical donor

Abbreviation: RID

Synonym: related HLA-identical donor

immunodiffusion

(ĭm″ū-nō-dĭ-fū′zhŭn) [ immuno- + diffusion]

A test method in which an antigen and antibody are placed in a gel, where they diffuse toward each other. When they meet, a precipitate is formed.

radial immunodiffusion

Abbreviation: RID

A means of measuring the amount of antigen in a sample in which a solution containing the antigen is dropped into a gel evenly impregnated with antibody. The diameter of the ring that precipitates around the solution varies directly with the amount of antigen in the solution.

radial immunodiffusion

Abbreviation: RID

Patient discussion about RID

Q. Can you get rid of endometriosis?

A. Currently, there is no known cure for endometriosis. Nevertheless, a hysterectomy and/or removal of the ovaries will not guarantee that the endometriosis areas or the symptoms of endometriosis will not come back, since adhesions can be found on other organs besides the reproductive organs. Surgical treatment tends to be conservative, with the goal of addressing pain or infertility issues through removal of the endometriosis tissue without damaging normal tissue. Several medication are known to be helpful occasionally, such as hormones (Progesterone or Progestins),combined oral contraceptive pills, Gonadotropin Releasing Hormone (GnRH) Agonists and more. You should consult your OB/GYN physician about the treatment best suitable for you.

Q. How do I get rid of allergy "shiners"? I get these dark circles under my eyes, especially when my allergies are bad. Make up helps but not a lot. I take a multi vitamin suppliment daily and that has no effect on it. It looks like I've been up for days sometimes or in some sort of fight. Any advise out there?

A. some courses of action, the best way is just to avoid the allergen- but you probably knew that... another method is applying cool tea bags, an ice cube wrapped in soft cloth, or cucumber slices to your eyes daily. The tannin in tea bags has been shown to reduce swelling and discoloration. Lie down, preferably in the morning, and leave fresh cucumber slices or cool, damp caffeinated tea bags (you can refrigerate them overnight so they’ll be ready) over your eyes for about 10-15 minutes. Keep your eyes close :)

Q. how can you get rid of anxiety attacks

A. Meditation helped me get over mine a great deal. Also, my anxiety attacks were deeply tied to school so I used an NLP (Neuro-Linguistic-Programming) technique to associate positive things with school and negative things to not going.

More discussions about RID

This content is provided by iMedix and is subject to iMedix Terms. The Questions and Answers are not endorsed or recommended and are made available by patients, not doctors.

auranofin

(au-rane-oh-fin) ,

Ridaura

(trade name)

Classification

Therapeutic: antirheumatics

Pregnancy Category: C

Indications

Treatment of progressive rheumatoid arthritis resistant to conventional therapy.

Action

Inhibits inflammatory process.

Modifies immune response (immunomodulating properties).

Therapeutic effects

Relief of pain and inflammation.

Slowing of the disease process in rheumatoid arthritis.

Pharmacokinetics

Absorption: 20–25% absorbed from the GI tract.

Distribution: Widely distributed; appears to concentrate in arthritic joints more than in uninvolved joints. Enters breast milk.

Metabolism and Excretion: 60% of absorbed dose slowly excreted by the kidneys; 40% of absorbed dose excreted in the feces.

Half-life: 26 days in blood, 40–128 days in tissue.

Time/action profile (anti-inflammatory activity)

ROUTE	ONSET	PEAK	DURATION
PO	3–6 mo	unknown	unknown

Contraindications/Precautions

Contraindicated in: Hypersensitivity; Previous gold toxicity (e.g. anaphylaxis, necrotizing enterocolitis, pulmonary fibrosis, exfoliative dermatitis, bone marrow aplasia, hematologic disorders); Obstetric: Potential for congenital anomalies; Lactation: Appears in breast milk. Use formula or discontinue auranofin.

Use Cautiously in: History of blood dyscrasias; Rashes; Severe hepatic or renal dysfunction; Inflammatory bowel disease; Patients taking other immunosuppressant drugs; Pediatric: Efficacy and safety not established.

Adverse Reactions/Side Effects

Central nervous system

peripheral neuropathy

Ear, Eye, Nose, Throat

conjunctivitis
corneal gold deposition

Genitourinary

proteinuria,
hematuria

Respiratory

bronchitis
pulmonary fibrosis
pneumonitis

Cardiovascular

bradycardia

Gastrointestinal

gi bleeding (life-threatening)
abdominal pain (most frequent)
cramping (most frequent)
diarrhea (most frequent)
gingivitis
glossitis
metallic taste
stomatitis (most frequent)
anorexia
difficulty swallowing
↑ liver enzymes
dyspepsia
flatulence
nausea
vomiting

Dermatologic

dermatitis (most frequent)
rash (most frequent)
alopecia
urticaria
photosensitivity reactions
pruritus (most frequent)

Hematologic

agranulocytosis (life-threatening)
aplastic anemia (life-threatening)
thrombocytopenia
anemia
eosinophilia
leukopenia

Miscellaneous

allergic reactions, including anaphylaxis (life-threatening)
angioedema (life-threatening)

Interactions

Drug-Drug interaction

Bone marrow toxicity may be additive with other myelosuppressive agents (antineoplastics, radiation therapy, azathioprine ) or high doses of corticosteroids.Concurrent use with penicillamine ↑ the risk of adverse hematologic or renal reactions.May ↑ blood levels of phenytoin.

Route/Dosage

Oral (Adults) 6 mg/day in 1–2 doses; may ↑ to 9 mg/day in 3 divided doses if no improvement after 6 mo.

Availability

Capsules: 3 mg

Nursing implications

Nursing assessment

Assess range of motion and degree of swelling and pain in affected joints before and periodically throughout therapy.
Lab Test Considerations: Monitor renal, hepatic, and hematologic function and urinalysis before and monthly during therapy. May cause thrombocytopenia, leukopenia, and anemia. May also cause ↑ liver enzymes, proteinuria, and hematuria.

Rapid decrease in hemoglobin, WBC <4000/mm³, granulocytes <1500/mm³, or platelets <150,000/mm³, albuminuria, hematuria, rash, dermatitis, pruritus, skin eruption, stomatitis, persistent diarrhea, jaundice, or petechiae may indicate gold toxicity. Withhold therapy until toxicity has been ruled out. If signs of overdose occur, corticosteroids are usually used to reverse effects. A chelating agent, dimercaprol (BAL), may be given to enhance gold excretion when corticosteroids are ineffective.

Potential Nursing Diagnoses

Impaired physical mobility (Indications)
Diarrhea (Side Effects)

Implementation

Oral: Administer with meals to minimize gastric irritation.

Patient/Family Teaching

Instruct patient to take medication exactly as directed; do not skip or double doses. Take missed dose as soon as possible except if next dose is almost due.
Concurrent therapy with salicylates or other NSAIDs or corticosteroids is usually necessary, especially during the first few months of gold therapy. Patients should continue physical therapy and ensure adequate rest. Explain that joint damage will not be reversed; the goal is to slow or stop the disease process.
Emphasize the importance of good oral hygiene to reduce stomatitis.
Caution patient to use sunscreen and protective clothing to prevent photosensitivity reactions.
Instruct patient to report symptoms of leukopenia (fever, sore throat, signs of infection); thrombocytopenia (bleeding gums; bruising; petechiae; blood in stools, urine, or emesis); or gold toxicity immediately. Diarrhea may be resolved by decreasing the dose.
Emphasize the importance of regular visits to health care professional to monitor progress and evaluate blood and urine tests for side effects.
Discuss the need for contraception while receiving this medication. Advise female patients to notify health care professional promptly if pregnancy is suspected.

Evaluation/Desired Outcomes

Decrease in swelling, pain, and stiffness of joints.
- Increase in mobility. Continuous therapy for 3–6 mo may be required before therapeutic effects are seen.

Ridaura

(rĭd-ô′rə)

A trademark for the drug auranofin.

Ridaura

A brand name for AURANOFIN.

Latest Searches:
zymosterol - zymosan - zymoplastic - Zymomonas - zymogenous - zymogenic - zymogen - zymochemistry - Zyme - Zymaxid - Zyloprim - Zymase - Zymar - Zylet - zygotic - zygote - zygotene - zygostyle - zygospore - zygosphere -
- Service manuals - MBI Corp